Acinetobacter baumannii—a multidrug-resistant (MDR) pathogen that causes, for example,
skin and soft tissue wounds; urinary tract infections; pneumonia; bacteremia; and …

Abstract In 2016, a 68-year-old patient with a disseminated multidrug-resistant Acinetobacter
baumannii infection was successfully treated using lytic bacteriophages. Here we report the …

Acinetobacter baumannii is an important nosocomial and opportunistic pathogen. It causes
infections worldwide, especially in intensive care units. It is clinically significant owing to its …

Acinetobacter baumannii is an opportunistic pathogen that significantly causes hospital-
acquired infections. Due to its multidrug resistance, treating infections caused by this …

Acinetobacter baumannii is a critical priority nosocomial pathogen that produces a variety of
capsular polysaccharides (CPSs), the primary receptors for specific depolymerase-carrying …

The type of capsular polysaccharide (CPS) on the cell surface of Acinetobacter baumannii
can determine the specificity of lytic bacteriophage under consideration for therapeutic use …

Infections with the opportunistic Gram-negative bacterium Acinetobacter baumannii pose a
serious threat today, which is aggravated by the growing problem of multi-drug resistance …

Much knowledge about bacteriophages has been obtained via genomics and
metagenomics over the last decades. However, most studies dealing with prophage …

Phage therapy offers a promising approach to combat the growing threat of antimicrobial
resistance. Yet, key questions remain regarding dosage, administration routes, combination …

The study of bacteriophages is experiencing a resurgence owing to their antibacterial
efficacy, lack of side effects, and low production cost. Nonetheless, the interactions between …